Revive Therapeutics Ltd (RVVTF)

[hotmeat]

I went through, I believe, all our likely competition from Big Pharma to become the first Oral Therapeutic/Prophylactic for treating mild/moderate Covid.

In terms of safety profile, Bucillamine wins hands down by having the mildest and least bothersome side effects, IF ANY at all, compared to the rest.

In addition to this it's been safely used in Asia for over 30 years with little to no adverse indications.

Going through the listed side effects of the other drugs is in most cases, cringeworthy, to put it mildly.

Molnupiravir, the "Media's" latest darling, is promise but there are still questions about it's effectiveness and most alarmingly, concerns about it's potentially mutagenic side effects.